778 results on '"Hasford, Joerg"'
Search Results
2. Correct use of non-indexed eGFR for drug dosing and renal drug-related problems at hospital admission
3. The EUTOS long-term survival (ELTS) score is superior to the Sokal score for predicting survival in chronic myeloid leukemia
4. Arzneimittelprüfung an nicht einwilligungsfähigen Erwachsenen: Kritische Bewertung der neuen gesetzlichen Regelung durch medizinische Ethikkommissionen in Deutschland
5. Epidemiology and Etiology of Chronic Myeloid Leukemia
6. Challenges and proposed solutions in making clinical research on COVID-19 ethical: a status quo analysis across German research ethics committees
7. Efficacy of vildagliptin for prevention of postpartum diabetes in women with a recent history of insulin-requiring gestational diabetes: A phase II, randomized, double-blind, placebo-controlled study
8. Medizinische Ethikkommissionen in der Bundesrepublik Deutschland: Entstehung und Einbindung in die medizinische Forschung
9. Prognostic Scores for Patients with Chronic Myeloid Leukemia Under Particular Consideration of Disease-Specific Death
10. Redundant trials can be prevented, if the EU clinical trial regulation is applied duly
11. Defining therapy goals for major molecular remission in chronic myeloid leukemia: results of the randomized CML Study IV
12. Erratum zu: Arzneimittelprüfung an nicht einwilligungsfähigen Erwachsenen: Kritische Bewertung der neuen gesetzlichen Regelung durch medizinische Ethikkommissionen in Deutschland
13. Impact of comorbidities on overall survival in patients with chronic myeloid leukemia: results of the randomized CML Study IV
14. Die EU-Verordnung 536/2014 und ihr Einfluss auf die Aufgaben und Arbeitsweisen der Ethikkommissionen in Deutschland
15. Systematic review and meta-analysis of standard-dose imatinib vs. high-dose imatinib and second generation tyrosine kinase inhibitors for chronic myeloid leukemia
16. Factors influencing adherence in CML and ways to improvement: Results of a patient-driven survey of 2546 patients in 63 countries
17. Ethische Aspekte der klinischen Prüfung bei seltenen Erkrankungen
18. No influence of BCR-ABL1 transcript types e13a2 and e14a2 on long-term survival: results in 1494 patients with chronic myeloid leukemia treated with imatinib
19. Etiology and Epidemiology of Chronic Myeloid Leukemia
20. Inhaled beta-2-agonists/muscarinic antagonists and acute myocardial infarction in COPD patients
21. Validation of the revised International Prognostic Scoring System (IPSS-R) in patients with myelodysplastic syndrome: A multicenter study
22. Epidemiology and Etiology of Chronic Myeloid Leukemia
23. Improved survival boosts the prevalence of chronic myeloid leukemia: predictions from a population-based study
24. Use LABAs only when asthma cannot be controlled otherwise
25. Medical registries represent vital patient interests and should not be dismantled by stricter regulation
26. Impact of unbalanced minor route versus major route karyotypes at diagnosis on prognosis of CML
27. A multi-state model approach for prediction in chronic myeloid leukaemia
28. Prognostic scores for patients with chronic myeloid leukemia under particular consideration of competing causes of death
29. Costs of Adverse Drug Events in German Hospitals—A Microcosting Study
30. Prediction of post-remission survival in acute myeloid leukaemia: a post-hoc analysis of the AML96 trial
31. Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV
32. Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS score
33. Four reasons why too many informed consents to clinical research are invalid: a critical analysis of current practices
34. Equivalence of BCR-ABL transcript levels with complete cytogenetic remission in patients with chronic myeloid leukemia in chronic phase
35. Sources of European drug consumption data at a country level
36. Explaining survival differences between two consecutive studies with allogeneic stem cell transplantation in patients with chronic myeloid leukemia
37. Older patients with chronic myeloid leukemia (≥65 years) profit more from higher imatinib doses than younger patients: a subanalysis of the randomized CML-Study IV
38. Self-Medication with Over-the-Counter and Prescribed Drugs Causing Adverse-Drug-Reaction-Related Hospital Admissions: Results of a Prospective, Long-Term Multi-Centre Study
39. Younger patients with chronic myeloid leukemia do well in spite of poor prognostic indicators: results from the randomized CML study IV
40. Tiotropium Respimat® vs. HandiHaler®: real-life usage and TIOSPIR trial generalizability
41. Allogeneic hematopoietic stem cell transplantation (allo SCT) for chronic myeloid leukemia in the imatinib era: evaluation of its impact within a subgroup of the randomized German CML Study IV
42. Möglichkeiten und Grenzen des Wirksamkeitsnachweises beim niedergelassenen Allgemeinarzt aus der Sicht der medizinischen Biometrie
43. Supplementation with Bifidobacterium longum subspecies infantis EVC001 for mitigation of type 1 diabetes autoimmunity: the GPPAD-SINT1A randomised controlled trial protocol
44. In patients with myelodysplastic syndromes with del(5q), factors other than age and sex contribute to the prognostic advantage, which diminishes over time
45. Epidemiology of chronic myeloid leukaemia (CML)
46. A population-based study comparing biosimilar versus originator erythropoiesis-stimulating agent consumption in 6,117 patients with renal anaemia
47. A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma
48. In memoriam: Ronald D. Mann, MD, FRCP, FRCGP, FFPM, FISPE, Professor Emeritus, Honorary Lifetime ISPE Fellow, 1928–2013: Perspectives of ISPEʼs Founding Executuve Director
49. Bridging Differences in Outcomes of Pharmacoepidemiological Studies: Design and First Results of the PROTECT Project
50. Benefit Assessment in Germany
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.